Summary:
Dosing of approved drug Mesalamine in children and adolescent patients with ulcerative colitis.
Qualified Participants Must:
Male or Female between the ages of 5 and 17yrs,inclusive
mildly or moderately active ulcerative colitis
able to swallow Asacol tablets(400mg)
body wt no less than 10kg and no more than 90kg(between 22 and 198 lbs)
Qualified Participants May Receive:
Compensated appropriately for time and travel.